ExesaLiberoPharma was awarded a Phase II Small Business Technology

10/03/2020

ExesaLiberoPharma was awarded a Phase II Small Business Technology Transfer (STTR) grant from the National Institute for Arthritis and Musculoskeletal Diseases (NIAMS) of the National Institutes of Health